Skip to main content

Table 1 Comparison of preoperative general data between the two groups

From: Efficacy and safety of double endoscopy combined with exploration in the treatment of elderly patients with cholecystolithiasis complicated with choledocholithiasis

Variables

the elderly group

(n = 63)

the young and middle-aged group(n = 51)

χ²/t

P value

Sex (M/F)

31/32

22/29

0.417

0.518

ALT(U/L)

119.2 ± 97.8

145.4 ± 101.6

-1.401

0.164

AST(U/L)

142.5 ± 203.8

141.9 ± 131.3

0.018

0.986

ALP(U/L)

358.0 ± 309.5

312.0 ± 199.1

0.958

0.340

Albumin(g/L)

35.3 ± 5.0

36.1 ± 5.3

-0.835

0.405

WBC (109/l)

7.6 ± 5.3

7.7 ± 4.9

-0.044

0.965

TBIL(µmol/L)

50. 1 ± 51.6

51.8 ± 28.6

-0.223

0.824

GGT(U/L)

494.6 ± 530.5

529.4 ± 442.4

-0.375

0.708

Diameter of CBD (mm)

14.2 ± 3.6

13.5 ± 3.4

1.154

0.251

Choledocholithiasis (single/multiple)

23/40

17/34

0.125

0.844

Cholecystolithiasis (single/multiple)

35/28

29/22

0.020

1.0

Diabetes

8(12.7%)

3(5.9%)

1.502

0.340

Hypertension

16(25.4%)

7(13.7%)

2.384

0.160

Hyperlipidemia

1(1.6%)

4(7.8%)

2.630

0.171

Lung diseases

2(3.2%)

0(0%)

1.648

0.501

Brain diseases

3(4.8%)

1(2.0%)

0.653

0.627

History of abdominal surgery

4(6.3%)

3(5.9%)

0.011

1.0

Pancreatitis

1(1.6%)

1(2.0%)

0.023

1.0

Epigastric pain

60(95.2%)

46(90.2%)

1.098

0.464

Nausea and vomiting

21(33.3%)

13(25.5%)

0.828

0.414

Fever

4(6.3%)

6(11.8%)

1.033

0.339

Jaundice

7(11. 1%)

11(21.6%)

2.318

0.196

  1. Note: patients in the elderly group were ≥ 60 years old and those in the young and middle-aged group were < 60 years old. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; Tbil: Total bilirubin; GGT: Gamma-glutamyl transferase